| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 7 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. CRBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $22.84M | - | |
| CEO | 188.2K | $1.83M | - | |
| CFO | 101.4K | $987.6K | - | |
| Other | 99.2K | $965.9K | - | |
| Other | 75.3K | $733.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 15, 2018 | White Barbara | Chief Medical Officer | Buy | 2,586 | $5.87 | $15,174.39 | +1.5% | |
| May 15, 2018 | Cohen Yuval65 | Chief Executive Officer | Buy | 1,725 | $5.85 | $10,091.25 | +2.9% | |
| May 15, 2018 | Moran Sean F.61 | Chief Financial Officer | Buy | 4,000 | $5.77 | $23,080.00 | +1.2% | |
| May 14, 2018 | Hochman David P | Director | Buy | 5,000 | $5.48 | $27,375.00 | New | |
| Mar 14, 2018 | Hochman David P | Director | Buy | 5,000 | $6.67 | $33,325.00 | +2.3% | |
| Mar 14, 2018 | White Barbara | Chief Medical Officer | Buy | 2,885 | $6.89 | $19,877.65 | +1.7% | |
| Mar 14, 2018 | Cohen Yuval65 | Chief Executive Officer | Buy | 1,160 | $6.89 | $7,986.60 | +2.0% | |
| Mar 14, 2018 | Moran Sean F.61 | Chief Financial Officer | Buy | 3,100 | $6.60 | $20,460.00 | +0.9% | |
| Nov 16, 2017 | Panayiotopoulos Paris | Director | Buy | 14,285 | $7.03 | $100,392.12 | New | |
| Nov 15, 2017 | Hochman David P | Director | Buy | 5,000 | $6.55 | $32,750.00 | +2.3% |